135 related articles for article (PubMed ID: 35652619)
1. LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis.
Chen KY; Zhu SG; He JW; Duan XP
Neoplasma; 2022 Jul; 69(4):918-930. PubMed ID: 35652619
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.
Ji D; Jiang C; Zhang L; Liang N; Jiang T; Yang B; Liang H
J Cell Physiol; 2019 May; 234(5):6548-6560. PubMed ID: 30230527
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma.
Xie SC; Zhang JQ; Jiang XL; Hua YY; Xie SW; Qin YA; Yang YJ
Cell Death Dis; 2020 Aug; 11(8):676. PubMed ID: 32826865
[TBL] [Abstract][Full Text] [Related]
6. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long noncoding RNA colorectal neoplasia differentially expressed inhibits hepatocellular carcinoma progression by mediating the expression of nuclear autoantigenic sperm protein.
Zhu Y; Li B; Xu G; Han C; Xing G
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34633056
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk of LncRNA HOTAIR and SP1-mediated repression of PDK1 contributes to β-Elemene-inhibited proliferation of hepatocellular carcinoma cells.
Wu J; Tang X; Shi Y; Ma C; Zhang H; Zhang J; Lu Y; Wei J; Li L; Han L
J Ethnopharmacol; 2022 Jan; 283():114456. PubMed ID: 34333105
[TBL] [Abstract][Full Text] [Related]
9. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.
Liu YC; Lin YH; Chi HC; Huang PS; Liao CJ; Liou YS; Lin CC; Yu CJ; Yeh CT; Huang YH; Lin KH
Clin Epigenetics; 2022 Aug; 14(1):106. PubMed ID: 35999564
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
[TBL] [Abstract][Full Text] [Related]
11. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
[TBL] [Abstract][Full Text] [Related]
12. Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma.
Zhu L; Liu Y; Chen Q; Yu G; Chen J; Chen K; Yang N; Zeng T; Yan S; Huang A; Tang H
Cell Physiol Biochem; 2018; 50(6):2229-2248. PubMed ID: 30423553
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
Han S; Han B; Li Z; Sun D
Cell Cycle; 2019 Oct; 18(19):2524-2537. PubMed ID: 31416393
[TBL] [Abstract][Full Text] [Related]
14. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway.
Pan W; Li W; Zhao J; Huang Z; Zhao J; Chen S; Wang C; Xue Y; Huang F; Fang Q; Wang J; Brand D; Zheng SG
Mol Oncol; 2019 Oct; 13(10):2246-2258. PubMed ID: 31368655
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
[TBL] [Abstract][Full Text] [Related]
19. LncRNA
Li X; Liang S; Fei M; Ma K; Sun L; Liu Y; Liu L; Wang J
Int J Biol Sci; 2024; 20(2):718-732. PubMed ID: 38169579
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt /β-catenin signaling.
Tang Q; Zheng X; Zhang J
Biomed Pharmacother; 2018 Jul; 103():1187-1193. PubMed ID: 29864897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
